Assignee
ASTERION LTD
GB·4 granted patents·12 pending applications·12 citations·filing 2001–2016
Top patents by PatentIndex Score
16 records- 0173US7446183B2Fusion protein comprising growth hormone and growth hormone receptorASTERION LTD·Filed 2001·Granted Nov 4, 2008·7 cites·35 claims
- 0269US7524649B2Modified growth hormone fusion polypeptidesASTERION LTD·Filed 2002·Granted Apr 28, 2009·5 cites·25 claims
- 0357US7625998B2Cytokine polypeptides and antibodies containing a signal sequence for the attachment of glycosylphosphatidylinositolASTERION LTD·Filed 2004·Granted Dec 1, 2009·0 cites·5 claims
- 0456US2009239801A1Modified Fusion PolypeptidesASTERION LTD·Filed 2009·Application pending·0 cites
- 0555US2009270325A1Growth factorASTERION LTD·Filed 2007·Application pending·0 cites
- 0650US2007054364A1Polypeptide variantsASTERION LTD·Filed 2006·Application pending·0 cites
- 0748US2011275564A1ErythropoietinASTERION LTD·Filed 2008·Application pending·0 cites
- 0847US2011152187A1Insulin-like growth factor fusion proteinsASTERION LTD·Filed 2008·Application pending·0 cites
- 0947US2011182848A1Granulocyte colony stimulating factorASTERION LTD·Filed 2008·Application pending·0 cites
- 1046US7485713B2Polypeptides comprising growth hormone receptor extracellular domain and glycosylphosphatidylinositolASTERION LTD·Filed 2002·Granted Feb 3, 2009·0 cites·10 claims
- 1146US2005214762A1Polypeptide variantsASTERION LTD·Filed 2003·Application pending·0 cites
- 1246US2011092417A1Leptin fusion proteinsASTERION LTD·Filed 2008·Application pending·0 cites
- 1343US2010035804A1Polypeptide antagonistASTERION LTD·Filed 2007·Application pending·0 cites
- 1440US2010316604A1Interferon lambda fusion polypeptidesASTERION LTD·Filed 2010·Application pending·0 cites
- 1539US2009221477A1LinkersASTERION LTD·Filed 2005·Application pending·0 cites
- 1635US2019085042A1Fusion polypeptide comprising the extracellular binding domain of growth hormone receptorASTERION LTD·Filed 2016·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →